Cargando…
Mucosal immune responses in COVID19 - a living review
COVID-19 was initially characterized as a disease primarily of the lungs, but it is becoming increasingly clear that the SARS-CoV2 virus is able to infect many organs and cause a broad pathological response. The primary infection site is likely to be a mucosal surface, mainly the lungs or the intest...
Autores principales: | Pearson, Claire F, Jeffery, Rebecca, Thornton, Emily E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7871424/ https://www.ncbi.nlm.nih.gov/pubmed/33585820 http://dx.doi.org/10.1093/oxfimm/iqab002 |
Ejemplares similares
-
T cell phenotypes in COVID-19 - a living review
por: Hanna, Stephanie J, et al.
Publicado: (2020) -
PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine
por: Rioux, Gervais, et al.
Publicado: (2014) -
Potential immune response to breast implants after immunization with COVID-19 vaccines
por: Weitgasser, Laurenz, et al.
Publicado: (2021) -
Serum extracellular vesicles profiling is associated with COVID‐19 progression and immune responses
por: Yim, Kevin Ho Wai, et al.
Publicado: (2022) -
Rumen-protected glucose supplementation in transition dairy cows shifts fermentation patterns and enhances mucosal immunity
por: Zhang, Xiaoli, et al.
Publicado: (2021)